Sanjeevani Pathology Labs was acquired by Carlyle and KKR backed diagnostic chain Metropolis

2 February 2022

Wodehouse Capital acted as advisor to the shareholders of Sanjeevani Pathology Labs in the sale of the company to PE backed Metropolis which will strengthen the latter’s market share as well penetration in Western India

Company:

Sanjeevani Pathology Labs

Transaction:

Sale

Sector:

Healthcare

Date:

January 31 2017

Country:

India

Activity:

Diagnostic services

Founded in 1993, Sanjeevani Pathology Laboratory provided pathological and diagnostic laboratory facilities in western India.

It has four labs and seven collection centres with a team of six senior pathologists including founder and promoter Kirit Patel.

This transaction was undertaken by Metropolis to establish a stronger presence in western India.

Sanjeevani is reported to be PE backed Metropolis's largest laboratory acquisition in India.

This will now be part of the 150 medical laboratories with over 1000 collection centres that IPO bound Metropolis has.

 

All transactions